TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Bionord Biokemi AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
5,539
|
5,895
|
6,267 |
| Financial expenses |
0
|
0
|
1 |
| Earnings before taxes |
656
|
635
|
644 |
| EBITDA |
650
|
635
|
649 |
| Total assets |
2,456
|
2,245
|
2,593 |
| Current assets |
2,238
|
2,020
|
2,363 |
| Current liabilities |
799
|
651
|
1,082 |
| Equity capital |
1,399
|
1,349
|
1,285 |
| - share capital |
44
|
45
|
45 |
| Employees (average) |
5
|
6
|
5 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
57.0%
|
60.1%
|
49.6% |
| Turnover per employee |
1,108
|
982
|
1,253 |
| Profit as a percentage of turnover |
11.8%
|
10.8%
|
10.3% |
| Return on assets (ROA) |
26.7%
|
28.3%
|
24.9% |
| Current ratio |
280.1%
|
310.3%
|
218.4% |
| Return on equity (ROE) |
46.9%
|
47.1%
|
50.1% |
| Change turnover |
-156
|
-390
|
1,494 |
| Change turnover % |
-3%
|
-6%
|
31% |
| Chg. No. of employees |
-1
|
1
|
0 |
| Chg. No. of employees % |
-17%
|
20%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.